| Product Code: ETC7658387 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel`s import of pancrelipase saw a diverse range of top exporting countries including Switzerland, UK, Belgium, USA, and Germany. The Herfindahl-Hirschman Index (HHI) indicated low market concentration, suggesting a competitive landscape. Despite a negative compound annual growth rate (CAGR) of -2.14% from 2020 to 2024, the growth rate improved slightly in 2024 with a decrease of only -0.41% compared to the previous year. This data highlights the steady but challenging market conditions for pancrelipase imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pancrelipase Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pancrelipase Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pancrelipase Market - Industry Life Cycle |
3.4 Israel Pancrelipase Market - Porter's Five Forces |
3.5 Israel Pancrelipase Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.6 Israel Pancrelipase Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Pancrelipase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Pancrelipase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pancreatic disorders and diseases in Israel |
4.2.2 Growing awareness about the benefits of pancrelipase in managing pancreatic insufficiency |
4.2.3 Rising healthcare expenditure in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost associated with pancrelipase medications |
4.3.3 Limited availability of specialized healthcare professionals for pancreatic care in Israel |
5 Israel Pancrelipase Market Trends |
6 Israel Pancrelipase Market, By Types |
6.1 Israel Pancrelipase Market, By Age |
6.1.1 Overview and Analysis |
6.1.2 Israel Pancrelipase Market Revenues & Volume, By Age, 2021- 2031F |
6.1.3 Israel Pancrelipase Market Revenues & Volume, By Children, 2021- 2031F |
6.1.4 Israel Pancrelipase Market Revenues & Volume, By Adults and Geriatrics, 2021- 2031F |
6.2 Israel Pancrelipase Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Pancrelipase Market Revenues & Volume, By Chronic Pancreatitis, 2021- 2031F |
6.2.3 Israel Pancrelipase Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.4 Israel Pancrelipase Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Pancrelipase Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Pancrelipase Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.3 Israel Pancrelipase Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.4 Israel Pancrelipase Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
7 Israel Pancrelipase Market Import-Export Trade Statistics |
7.1 Israel Pancrelipase Market Export to Major Countries |
7.2 Israel Pancrelipase Market Imports from Major Countries |
8 Israel Pancrelipase Market Key Performance Indicators |
8.1 Patient adherence rates to pancrelipase treatment |
8.2 Number of clinical trials and research studies conducted on pancrelipase in Israel |
8.3 Adoption rate of advanced pancrelipase formulations |
8.4 Patient satisfaction and reported quality of life improvements with pancrelipase therapy |
9 Israel Pancrelipase Market - Opportunity Assessment |
9.1 Israel Pancrelipase Market Opportunity Assessment, By Age, 2021 & 2031F |
9.2 Israel Pancrelipase Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Pancrelipase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Pancrelipase Market - Competitive Landscape |
10.1 Israel Pancrelipase Market Revenue Share, By Companies, 2024 |
10.2 Israel Pancrelipase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here